Asset Dedication LLC Sells 43 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Asset Dedication LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 491 shares of the medical equipment provider’s stock after selling 43 shares during the quarter. Asset Dedication LLC’s holdings in Intuitive Surgical were worth $243,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. AlphaCore Capital LLC increased its position in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after buying an additional 18 shares in the last quarter. Accredited Investors Inc. grew its stake in Intuitive Surgical by 1.9% in the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider’s stock valued at $543,000 after acquiring an additional 19 shares during the period. Second Line Capital LLC increased its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock worth $302,000 after acquiring an additional 19 shares in the last quarter. Colonial Trust Co SC raised its position in Intuitive Surgical by 8.8% during the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider’s stock worth $128,000 after acquiring an additional 20 shares during the period. Finally, Crown Wealth Group LLC lifted its holdings in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 20 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company’s stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares of the company’s stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 over the last three months. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ISRG. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating and cut their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $592.59.

Intuitive Surgical Stock Down 2.7%

Shares of NASDAQ ISRG opened at $512.06 on Monday. The business’s 50 day moving average is $537.85 and its two-hundred day moving average is $536.67. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The firm has a market cap of $183.53 billion, a price-to-earnings ratio of 75.08, a PEG ratio of 5.43 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.